These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8865937)

  • 1. Tantalum stents induce expression of GMP140 and GP53 on platelets after contact in an in vitro model.
    Gutensohn K; Beythien C; Bau J; Meinertz T; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1996; 33():61-5. PubMed ID: 8865937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model.
    Gutensohn K; Beythien C; Bau J; Meinertz T; Kuehnl P
    Thromb Res; 1997 Apr; 86(1):49-56. PubMed ID: 9172286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of stent length and heparin coating on platelet activation: a flow cytometric analysis in a pulsed floating model.
    Beythien C; Gutensohn K; Bau J; Hamm CW; Kühnl P; Meinertz T; Terres W
    Thromb Res; 1999 Apr; 94(2):79-86. PubMed ID: 10230892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
    Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
    J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of heparin coating of coronary stents and ex vivo efficacy of different doses of acetylsalicylic acid and ticlopidine in a pulsed floating model of recirculating human plasma.
    Brockmann MA; Gutensohn K; Bau J; Kuehnl P; Meinertz T; Nienaber C; Beythien C
    Platelets; 2002 Dec; 13(8):443-9. PubMed ID: 12487777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system.
    Palmerini T; Coller BS; Cervi V; Tomasi L; Marzocchi A; Marrozzini C; Leone O; Piccioli M; Branzi A
    J Am Coll Cardiol; 2004 Oct; 44(8):1570-7. PubMed ID: 15489087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow-cytometric analysis of platelet activation during rotablation].
    Bau J; Gutensohn K; Kuck KH; Beythien C; Stein J; Kühnl P
    Z Kardiol; 2000 Jan; 89(1):15-20. PubMed ID: 10663912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of activation-dependent platelet antigens CD62p and CD63 during haemodialysis.
    Gutensohn K; Sputtek A; Voss A; Stahl RA; Kuehnl P
    Transfus Sci; 1996 Dec; 17(4):489-92. PubMed ID: 10168544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces.
    Hansi C; Arab A; Rzany A; Ahrens I; Bode C; Hehrlein C
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):488-96. PubMed ID: 19235237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
    Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
    J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
    Sandgren P; Hansson M; Gulliksson H; Shanwell A
    Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical outcome in patients after single vessel PTCA with multiple stent implantation].
    Pieniazek P; Przewłocki T; Zmudka K; Dudek D; Sedziwy E; Olszowska M; Kostkiewicz M; Kapelak B; Tracz W
    Przegl Lek; 2001; 58(6):479-83. PubMed ID: 11816735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silicon Carbide Coating Ñ A Semiconducting Hybrid Design of Coronary Stents Ñ A Feasibility Study.
    Heublein B; Pethig K; Elsayed AM
    J Invasive Cardiol; 1998 Jun; 10(5):255-262. PubMed ID: 10762797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation.
    Vidal C; Spaulding C; Picard F; Schaison F; Melle J; Weber S; Fontenay-Roupie M
    Thromb Haemost; 2001 Sep; 86(3):784-90. PubMed ID: 11583308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standards in interventional therapy of coronary artery disease].
    Rutsch W; Gliech V; Dübel HP; Borges A; Theres H; Laule M; Baumann G
    Herz; 2002 Sep; 27(6):481-501. PubMed ID: 12378393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
    Tutar E; Ozcan M; Kilickap M; Gülec S; Aras O; Pamir G; Oral D; Dandelet L; Key NS
    Circulation; 2003 Sep; 108(13):1581-4. PubMed ID: 12975255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of platelet activation following coronary angioplasty. Effect on acute occlusion and restenosis].
    Durrieu-Jaïs C; Macchi L; Bihour C; Coste P; Besse P; Nurden P; Nurden AT
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1259-65. PubMed ID: 8952823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.
    Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R
    Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.